• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Effects of Vaccination and Previous Infection on Omicron Infections in Children.

作者信息

Lin Dan-Yu, Gu Yu, Xu Yangjianchen, Zeng Donglin, Wheeler Bradford, Young Hayley, Sunny Shadia Khan, Moore Zack

机构信息

University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC

North Carolina Department of Health and Human Services, Raleigh, NC.

出版信息

N Engl J Med. 2022 Sep 22;387(12):1141-1143. doi: 10.1056/NEJMc2209371. Epub 2022 Sep 7.

DOI:10.1056/NEJMc2209371
PMID:36069811
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9511630/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbcf/9511630/d06fc012c65e/NEJMc2209371_f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbcf/9511630/d06fc012c65e/NEJMc2209371_f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbcf/9511630/d06fc012c65e/NEJMc2209371_f1.jpg

相似文献

1
Effects of Vaccination and Previous Infection on Omicron Infections in Children.疫苗接种和既往感染对儿童奥密克戎感染的影响。
N Engl J Med. 2022 Sep 22;387(12):1141-1143. doi: 10.1056/NEJMc2209371. Epub 2022 Sep 7.
2
How bad is Omicron? What scientists know so far.奥密克戎毒株有多严重？科学家目前所了解的情况。
Nature. 2021 Dec;600(7888):197-199. doi: 10.1038/d41586-021-03614-z.
3
Fast-spreading COVID variant can elude immune responses.快速传播的新冠病毒变种能够逃避免疫反应。
Nature. 2021 Jan;589(7843):500-501. doi: 10.1038/d41586-021-00121-z.
4
Hybrid Immunity More Protective Than Prior SARS-CoV-2 Infection Alone.混合免疫比单纯既往感染新冠病毒更具保护作用。
JAMA. 2023 Feb 21;329(7):531. doi: 10.1001/jama.2023.0743.
5
Meta-analysis of hybrid immunity to mitigate the risk of Omicron variant reinfection.奥密克戎变异株再感染风险的混合免疫元分析。
Front Public Health. 2024 Aug 26;12:1457266. doi: 10.3389/fpubh.2024.1457266. eCollection 2024.
6
Immunity to glycan α-Gal and possibilities for the control of COVID-19.对聚糖α-Gal的免疫及控制新冠病毒病的可能性
Immunotherapy. 2021 Feb;13(3):185-188. doi: 10.2217/imt-2020-0247. Epub 2020 Dec 14.
7
Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection.SARS-CoV-2 的持久免疫控制和预防再感染的前景。
Nat Rev Immunol. 2021 Jun;21(6):395-404. doi: 10.1038/s41577-021-00550-x. Epub 2021 Apr 29.
8
Six months of COVID vaccines: what 1.7 billion doses have taught scientists.新冠疫苗六个月：17亿剂疫苗带给科学家的启示
Nature. 2021 Jun;594(7862):164-167. doi: 10.1038/d41586-021-01505-x.
9
Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review.奥密克戎（B.1.1.529）-关注变异株-分子特征和流行病学：简要综述。
Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):8019-8022. doi: 10.26355/eurrev_202112_27653.
10
Long-term monitoring of SARS-CoV-2 seroprevalence and variants in Ethiopia provides prediction for immunity and cross-immunity.对埃塞俄比亚新冠病毒血清流行率和变异株的长期监测可为免疫和交叉免疫提供预测。
Nat Commun. 2024 Apr 24;15(1):3463. doi: 10.1038/s41467-024-47556-2.

引用本文的文献

1
Humoral and cellular immune responses in vaccinated and unvaccinated children following SARS-CoV-2 Omicron infection.SARS-CoV-2奥密克戎感染后接种疫苗和未接种疫苗儿童的体液免疫和细胞免疫反应。
Clin Transl Immunology. 2024 Oct 3;13(10):e70008. doi: 10.1002/cti2.70008. eCollection 2024.
2
T cell hybrid immunity against SARS-CoV-2 in children: a longitudinal study.儿童对 SARS-CoV-2 的 T 细胞混合免疫：一项纵向研究。
EBioMedicine. 2024 Jul;105:105203. doi: 10.1016/j.ebiom.2024.105203. Epub 2024 Jun 18.
3
Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis.

本文引用的文献

1
BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age.BNT162b2 疫苗对 5 至 11 岁儿童中奥密克戎的有效性。
N Engl J Med. 2022 Jul 21;387(3):227-236. doi: 10.1056/NEJMoa2205011. Epub 2022 Jun 29.
2
Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.在奥密克戎毒株占主导期间，既往BNT162b2型新冠疫苗接种与儿童及青少年有症状的新冠病毒感染之间的关联
JAMA. 2022 Jun 14;327(22):2210-2219. doi: 10.1001/jama.2022.7493.
3
BNT162b2 Protection against the Omicron Variant in Children and Adolescents.
儿科危重症 COVID-19 的危险因素：系统评价和荟萃分析。
J Pediatric Infect Dis Soc. 2024 Jul 20;13(7):352-362. doi: 10.1093/jpids/piae052.
4
Guidance for prevention and management of COVID-19 in children and adolescents: A consensus statement from the Pediatric Infectious Diseases Society Pediatric COVID-19 Therapies Taskforce.儿童和青少年 COVID-19 预防和管理指南：儿科传染病学会儿科 COVID-19 治疗工作组的共识声明。
J Pediatric Infect Dis Soc. 2024 Mar 19;13(3):159-185. doi: 10.1093/jpids/piad116.
5
Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis.儿童重症 COVID-19 的危险因素：系统评价与荟萃分析
medRxiv. 2024 Jan 18:2024.01.17.24301452. doi: 10.1101/2024.01.17.24301452.
6
Effectiveness of the BNT162b2 vaccine in preventing morbidity and mortality associated with COVID-19 in children aged 5 to 11 years: A systematic review and meta-analysis.BNT162b2疫苗在预防5至11岁儿童COVID-19相关发病和死亡中的有效性：一项系统评价和荟萃分析。
PLOS Glob Public Health. 2023 Dec 4;3(12):e0002676. doi: 10.1371/journal.pgph.0002676. eCollection 2023.
7
Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infection or vaccination in children.儿童感染 SARS-CoV-2 或接种疫苗后对奥密克戎 BQ.1、BQ.1.1 和 XBB.1 变异株的中和作用。
Nat Commun. 2023 Dec 1;14(1):7952. doi: 10.1038/s41467-023-43152-y.
8
Persistent humoral immune response in youth throughout the COVID-19 pandemic: prospective school-based cohort study.青少年在整个 COVID-19 大流行期间持续存在体液免疫反应：基于学校的前瞻性队列研究。
Nat Commun. 2023 Nov 27;14(1):7764. doi: 10.1038/s41467-023-43330-y.
9
Asthma and Susceptibility to COVID-19 in Australian Children During Alpha, Delta and Omicron Waves of the COVID-19 Pandemic.新冠疫情阿尔法、德尔塔和奥密克戎毒株流行期间澳大利亚儿童的哮喘与新冠病毒易感性
J Asthma Allergy. 2023 Oct 13;16:1139-1155. doi: 10.2147/JAA.S421158. eCollection 2023.
10
Application of a life table approach to assess duration of BNT162b2 vaccine-derived immunity by age using COVID-19 case surveillance data during the Omicron variant period.应用寿命表方法评估奥密克戎变异期间使用 COVID-19 病例监测数据按年龄划分的 BNT162b2 疫苗衍生免疫的持续时间。
PLoS One. 2023 Sep 20;18(9):e0291678. doi: 10.1371/journal.pone.0291678. eCollection 2023.
BNT162b2 对儿童和青少年奥密克戎变异株的保护效果。
N Engl J Med. 2022 May 19;386(20):1899-1909. doi: 10.1056/NEJMoa2202826. Epub 2022 Mar 30.
4
Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina.北卡罗来纳州 9 个月期间的新冠疫苗有效性。
N Engl J Med. 2022 Mar 10;386(10):933-941. doi: 10.1056/NEJMoa2117128. Epub 2022 Jan 12.